Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small-molecule SMAC mimetics as new cancer therapeutics
Longchuan Bai, David C. Smith, Shaomeng Wang
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 1, pp. 82-95
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin, Yinyan Tang, James A. Wells
Chemistry & Biology (2014) Vol. 21, Iss. 9, pp. 1102-1114
Open Access | Times Cited: 955
Apoptosis and apoptotic body: disease message and therapeutic target potentials
Xuebo Xu, Yueyang Lai, Zichun Hua
Bioscience Reports (2018) Vol. 39, Iss. 1
Open Access | Times Cited: 734
MOMP, cell suicide as a BCL-2 family business
Halime Kalkavan, Douglas R. Green
Cell Death and Differentiation (2017) Vol. 25, Iss. 1, pp. 46-55
Open Access | Times Cited: 553
Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Youry Kim, Jenny L. Anderson, Sharon R. Lewin
Cell Host & Microbe (2018) Vol. 23, Iss. 1, pp. 14-26
Open Access | Times Cited: 351
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
Yu‐Tzu Tai, Chirag Acharya, Gang An, et al.
Blood (2016) Vol. 127, Iss. 25, pp. 3225-3236
Open Access | Times Cited: 293
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Mansi Saxena, Garabet Yeretssian
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 234
Modulation of Protein–Protein Interactions for the Development of Novel Therapeutics
Ιωάννα Πέττα, Sam Lievens, Claude Libert, et al.
Molecular Therapy (2015) Vol. 24, Iss. 4, pp. 707-718
Open Access | Times Cited: 200
Mechanisms of Taxane Resistance
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 144
HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 143
Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways
Adeeb Derakhshan, Zhong Chen, Carter Van Waes
Clinical Cancer Research (2016) Vol. 23, Iss. 6, pp. 1379-1387
Open Access | Times Cited: 137
Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
Dauren Alimbetov, Sholpan Askarova, Bauyrzhan Umbayev, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1690-1690
Open Access | Times Cited: 135
BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency
Lars Pache, Míriam Santos Dutra, Adam M. Spivak, et al.
Cell Host & Microbe (2015) Vol. 18, Iss. 3, pp. 345-353
Open Access | Times Cited: 132
Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
Kathryn M. Pflug, Raquel Sitcheran
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8470-8470
Open Access | Times Cited: 131
XIAP deficiency syndrome in humans
Sylvain Latour, Claire Aguilar
Seminars in Cell and Developmental Biology (2015) Vol. 39, pp. 115-123
Closed Access | Times Cited: 129
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
Ravi K. Amaravadi, Russell J. Schilder, Lainie P. Martin, et al.
Molecular Cancer Therapeutics (2015) Vol. 14, Iss. 11, pp. 2569-2575
Open Access | Times Cited: 112
Exploiting poly(I:C) to induce cancer cell apoptosis
Francesca Bianchi, Samantha Pretto, Elda Tagliabue, et al.
Cancer Biology & Therapy (2017) Vol. 18, Iss. 10, pp. 747-756
Open Access | Times Cited: 109
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
Scott McComb, Júlia Aguadé-Gorgorió, Lena Harder, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 339
Closed Access | Times Cited: 106
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives
Hui Cong, Lijuan Xu, Yougen Wu, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 12, pp. 5750-5772
Closed Access | Times Cited: 94
Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity
Karoliina Tuomela, Ashley Ambrose, Daniel M. Davis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Small molecules targeting protein–protein interactions for cancer therapy
Defa Wu, Yang Li, Lang Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4060-4088
Open Access | Times Cited: 32
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
Iacovos N. Michaelides, Gavin W. Collie
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3173-3194
Open Access | Times Cited: 26
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia
Petra Nygren, Jonas Bouhlal, Emmi Jokinen, et al.
Blood (2025)
Open Access | Times Cited: 1
Programmed cell death in nasopharyngeal carcinoma: Mechanisms and therapeutic targets
Shen’er Qian, Guolin Tan, Guang Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 1, pp. 189265-189265
Closed Access | Times Cited: 1
X-linked Inhibitor of Apoptosis Protein Deficiency: More than an X-linked Lymphoproliferative Syndrome
Claire Aguilar, Sylvain Latour
Journal of Clinical Immunology (2015) Vol. 35, Iss. 4, pp. 331-338
Closed Access | Times Cited: 89
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
Wei Wang, Jiang‐Jiang Qin, Sukesh Voruganti, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top